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a b s t r a c t
Foot-and-mouth disease virus (FMDV) produces a disease in cattle characterized by vesicular lesions and
a persistent infection with asymptomatic low-level production of virus in pharyngeal tissues. Here we
describe the establishment of a persistently infected primary cell culture derived from bovine pharynx
tissue (PBPT) infected with FMDV serotype O1 Manisa, where surviving cells were serially passed until a
persistently infected culture was generated. Characterization of the persistent virus demonstrated
changes in its plaque size, ability to grow in different cell lines, and change in the use of integrins as
receptors, when compared with the parental virus. These results demonstrate the establishment of
persistently infected PBPT cell cultures where co-adaptation has taken place between the virus and host
cells. This in vitro model for FMDV persistence may help further understanding of the molecular
mechanisms of the cattle carrier state.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Foot-and-mouth disease virus (FMDV) is the type species of the
Aphthovirus genus within the Picornaviridae family. The positive-
stranded RNA virus has a genome of approximately 8400 nucleo-
tides. FMDV causes a highly contagious and economically impor-
tant disease in cloven-hoofed animals, including cattle, pigs, sheep
and goats, characterized by vesicular lesions in the mouth and on
the feet, teats and nares (Arzt et al., 2011; Grubman and Baxt,
2004). An important characteristic of the virus is its ability to
establish a persistent infection (the so-called “carrier state”) in up
to 50% of both vaccinated and non-vaccinated cattle, with asymp-
tomatic low-level excretion of virus from the pharyngeal region,
which has also been described as the primary site of replication
during the acute infection (Arzt et al., 2010; Burrows et al., 1971;
Pacheco et al., 2010)
The virus may persist in the esophageal pharyngeal (OP) region
of cattle and other ruminants (Salt, 2004; Sutmoller and Gaggero,
1965; Van Bekkum et al., 1959) for several years (Condy et al.,
1985) without causing signs of disease. The importance of carrier
animals in the epidemiology of FMDV has been a matter of debate
for many years. Although the risks that FMDV carriers pose to
susceptible animals are not well understood, control and eradica-
tion programs are complicated by the occurrence of the “carrier
state” (Alexandersen et al., 2002; Knowles and Samuel, 2003;
Ruiz-Saenz et al., 2009).
The mechanisms that mediate the establishment and maintenance
of persistence in vivo are almost completely unknown. It has been
previously suggested that the mechanisms for the establishment of
viral persistence within the host may be mediated by changes in the
virus, including the production of defective interfering particles,
temperature-sensitive mutants, virus recombination and the infection
of cells of the immune systemwith the concomitant alteration of their
function (Salt, 1993). Alternatively, persistence may be the result of a
dynamic equilibrium between the host immune response and the
selection of viral antigenic variants (Gebauer et al., 1988).
A number of studies have demonstrated the importance of the
tissues in the pharyngeal area during acute and persistent FMDV
infection (Arzt et al., 2010; Burrows et al., 1971; Pacheco et al.,
2010). In persistently FMDV-infected cattle, infectious virus and
viral RNA have been isolated from oropharyngeal ﬂuid samples
(Burrows et al., 1971) and bovine pharyngeal epithelia (Prato
Murphy et al., 1994), respectively. It also has been shown that
FMD viral RNA was localized within epithelial cells of the soft
palate and pharynx during persistent infection, suggesting that
persistence in vivo results from the combination of a very specia-
lized target epithelial cell population in the pharynx along with a
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speciﬁc cellular response, probably involving interferon and cyto-
kine production (Zhang and Kitching, 2001). It has also been
hypothesized that during persistence a cytokine response may
be involved in delaying or preventing infection of susceptible cells,
perhaps allowing clearance of the virus (Alexandersen et al.,
2002). To date, no mechanism has been experimentally shown to
be responsible for the establishment, maintenance or resolution of
the carrier status for FMD.
Study of the mechanisms regulating activities between virus
and host in persistently infected animals is complicated due to the
innumerable virus and host factors inﬂuencing the interaction.
Alternatively, the establishment of an in vitro model for FMDV
persistence could elucidate molecular mechanisms that mediate
evasion of host defenses and improve our understanding of the
carrier state. FMDV-persistent cultures have been established
using primary calf kidney cells by treating the cultures with
anti-FMDV hyperimmune serum obtained from tissues of conva-
lescent cattle, including bovine pharynx (Dinter et al., 1959;
Mohanty and Cottral, 1971; Seibold et al., 1964). These studies
demonstrated the persistence of FMDV in the cell cultures for
approximately 25 weeks, although no cell passages were
performed to establish a persistently infected cell line.
Other studies performed in vitro have focused on persistently
infected cell lines derived from non-susceptible FMDV species
(such as the baby hamster kidney cell line, BHK-21 or IBRS2) and
using plaque-puriﬁed laboratory-adapted strains of FMDV (de la
Torre et al., 1985). It was suggested that during serial passage of
the culture, a co-adaptation of persistent virus and the host cells
occurred, as reﬂected by an increased resistance of the cells to re-
infection when challenged with the parental virus and an
enhanced infectivity of the persistent virus for naive BHK-21 cells
(de la Torre and Domingo, 1988; de la Torre et al., 1989).
In this study, we report the establishment of an in vitro persistently
FMDV-infected primary cell culture derived from bovine pharynx
tissue (PBPT), a relevant bovine tissue as a primary site of virus
replication. The cells that survived the cytolytic infection were sub-
cultivated until persistence was established. Characterization of the
virus recovered from the persistent culture as well as characterization
of the persistently infected cells suggests that genetic and phenotypic
variations that develop during persistence may indicate a co-
adaptation of virus and host cells. The establishment of this persis-
tently FMDV-infected in vitro cell culture using a tissue critical during
in vivo infection in natural hosts may provide a model that allows co-
adaptation of both the virus and primary cells to study mechanisms of
induction and reactivation of FMDV in carrier animals.
Results and discussion
Characterization of bovine pharynx cell cultures
Non-infected PBPT cell cultures were phenotypically character-
ized at different passage numbers using direct immunoﬂuores-
cence and monoclonal antibodies (MAb) speciﬁc for critical cell
markers. Basically, FMDV integrin receptors, (αVβ1, αVβ3, αVβ5, and
αVβ6), an epithelial cell marker (cytokeratin) and a non-epithelial
cell marker (vimentin) were used for deﬁning cell phenotypes
present in these cell cultures. Low passage cell cultures were
positive for all integrins, most cells were cytokeratin positive
(480%), and less than 20% of the cells was positive for vimentin.
In contrast, at passage number 15, cells remained positive for all
integrins except αVβ6, a low percentage of cells was cytokeratin
positive (5–10%), and the majority of the cells (480%) expressed
vimentin (Fig. 1A). These results suggest that the number of non-
epithelial type cells increases with increasing passage number
while the epithelial-type cell population decreases.
Establishment of primary bovine pharynx cultures persistently
infected with FMDV
To establish the in vitro persistent culture, monolayers of PBPT
cultures were infected with the parental FMDV O1 Manisa
(O1Manisa-par) at an MOI of 1 pfu/cell. At 24 h post-infection
(hpi), approximately 80% of the cells exhibited CPE (Fig. 1B). The
cells that remained attached were provided with fresh medium
and regenerated a complete monolayer after 5–7 days of culture.
Cultures were subsequently passed by detaching the cells using
trypsin at intervals of 5–7 days. No evident CPE was observed from
passage 2 up to passage 23 when persistently infected cultures
were compared with the uninfected PBPT cultures (Fig. 1B).
The presence of virus during the serial passages of FMDV-
infected bovine pharynx cells was analyzed by real-time reverse
transcription PCR (RT-PCR) and IHC. The quantity of FMDV RNA
detected by real-time RT-PCR varied with different cell culture
passages. Ct values corroborate virus yields detected by plaque
assay (Fig. 1C). Infectious virus was present with titers ﬂuctuating
between 103 and 105 pfu/mL in the supernatant of cell cultures
from passages 2 to 23. FMDV antigens, analyzed by IHC (using a
speciﬁc MAb against viral structural protein VP1), were constantly
detected in cell cultures between passages 2 and 23. IHC of cell
cultures at passage 15 demonstrated the presence of FMDV
antigens in approximately 10% of the cells. Previous reports on
persistently infected cultures of BHK-21(de la Torre et al., 1985;
Donn et al., 1995; Martin-Acebes et al., 2010), IBRS-2 (de la Torre
et al., 1985) or calf kidney cell (Dinter et al., 1959) also showed low
percentages (0.05–10%) of infected cells without evidence of
cytopathic effect. These results indicate that the bovine pharynx
culture infected with FMDV O1Manisa-par became persistently
infected and continues to harbor FMDV without showing evident
cytopathic changes through 23 passages. Additional experiments
used persistently FMDV-infected bovine pharynx cultures that had
gone through at least 15 passages unless otherwise indicated.
Characterization of persistently FMDV-infected bovine pharynx cells
To determine the nature of the pharynx cells undergoing
persistent infection with FMDV, a double-IFA staining and confocal
microscopy were performed using MAb to the viral capsid protein
(VP1) as well as MAb to different cellular markers (cytokeratin,
integrin αVβ6 and vimentin). As stated earlier, after 15 passages
only a low percentage (approximately 10%) of cells in the persis-
tently infected PBPT cultures stained positive for viral antigen
(Fig. 2A). VP1 was distributed as granules with perinuclear
localization. Interestingly, none of the infected cells appeared
positive for cytokeratin or integrin αVβ6 (data not shown) but
were positive for vimentin (Fig. 2B).
To further characterize the localization of structural viral
protein VP1 in persistently infected cultures, double-label IFA
and confocal microscopy were utilized with monoclonal antibo-
dies to identify different intracellular structures and pathways
(Fig. 2B): actin and α-tubulin as markers for cytoskeleton; clathrin
heavy chain and caveolin-1 as markers for clathrin and caveolae
endocytosis pathways, respectively disulﬁde isomerase (PDI) as a
marker for endoplasmic reticulum; Golgi zone area MAb to detect
the Golgi apparatus; Rab11 as a marker to identify recycling
endosomes; proteosomes as a marker to determine if virus is
degraded in these structures. Results demonstrated that there is
no colocalization between FMDV VP1 and most of the cell
structures analyzed (Fig. 2B).
It is generally accepted that persistently FMDV-infected cattle
harbors the virus in the pharynx and dorsal soft palate which are
characterized by a highly specialized, non-corniﬁed, and stratiﬁed
squamous epithelia different from the surrounding epithelia
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(Alexandersen et al., 2002; Zhang and Kitching, 2001). The exact
type of cell(s) containing the virus has been under controversy.
FMDV RNA has been located in the cytoplasm of keratin-positive
cells belonging to the stratum germinativum of the epithelium
(Zhang and Kitching, 2001). Conversely, another study (Juleff et al.,
2008) was unable to identify FMDV RNA nor non-structural viral
proteins in epithelial cells of tonsils or dorsal soft palates in
persistently infected cattle. Interestingly, this study used laser
capture microscopy and immunohistochemical/in situ hybridiza-
tion analysis and found that FMDV is maintained in the light zone
of germinal centers and interfollicular regions of the palatine
tonsils or mandibular/retropharyngeal lymph nodes. Cells harbor-
ing virus did not express αvβ6, although this marker is abundantly
expressed in surrounding epithelial cells (Juleff et al., 2008). Thus,
based on the published data, there is no general consensus
regarding the characteristics and lineage of the cells harboring
the persistent virus in vivo.
Autophagy markers colocalized with FMDV in bovine pharynx
persistent cultures
Recent studies have shown that certain intracellular bacteria
and a number of positive-strand RNA viruses, including picorna-
viruses, induce the formation of autophagic membranes and
inhibit either their ﬁnal maturation or their ability to fuse with
lysosomes (Gladue et al., 2012; O’Donnell et al., 2011). As shown in
Fig. 2, the distribution of FMDV antigens in persistently infected
cells of the bovine pharynx resembles a vesicular structure, similar
to those associated with an autophagic origin. It has been previously
shown that FMDV transiently associates with autophagy structures
during the normal cycle of replication to later progress to a stage
associated with membranes in replication complexes (Gladue et al.,
2012; O’Donnell et al., 2011). Interestingly, a clear colocalization of LC3
(a speciﬁc marker for autophagosomes) with VP1 in passage 15 of
persistently infected PBPT cultures was observed (Fig. 3). This reactiv-
ity was constantly observed in samples obtained from PBPT cells
harboring O1Man-Ph15. Conversely, colocalization between VP1 and
LC3 in PBPT cultures infected with O1Manisa-par is a transient
phenomenon observed only at 3 hpi. In order to further conﬁrm the
involvement of the autophagy pathway during the persistent infection
of O1Man-Ph15 in PBPT cultures, the localization of VP1 with Atg5 or
Atg12, two proteins that are essential for autophagy formation, was
further examined. Persistently infected cells showed total colocaliza-
tion of the viral capsid protein with Atg5 and a partial colocalization
with Atg12 (Fig. 3). These results suggest that autophagy may play
a role during virus persistence, perhaps by maintaining the
virus structures protected from the host immune response effector
mechanisms.
Characterization of FMDV recovered from persistently infected
bovine pharynx cell cultures
To understand mechanisms mediating the adaptation of virus
to the host cell during the process of establishing persistence,
the virus obtained at passage 15 (O1Man-Ph15) was compared
with the original parental virus O1Manisa-par in its CPE, host
cell range of infectivity and plaque size. Plaque morphology
of the persistent virus O1Man-Ph15 was evaluated on LFBK
cells and compared to the parental virus O1Manisa-par. The
O1Manisa-par virus on LFBK cell cultures produced a large plaque
morphology (6–9 mm), while the persistent virus O1Man-Ph15
produced a much smaller plaque size (0.25–0.5 mm). The size of
the O1Man-Ph15 plaque was maintained unaltered up to 23
passages (Fig. 4A).
The ability of the persistent virus O1Man-Ph15 to replicate in a
number of different cell types (BHK-21, BHK-21αvβ6, LFBK, EBK,
FBK, FPK, SK-6 and IBRS-2 cells) was evaluated and compared
to the parental virus, O1Manisa-par. O1Manisa-par virus
Fig. 1. Characterization of a persistent FMDV-infected bovine pharynx cell culture. (A) Distribution of FMDV integrin receptors (αvβ1, αvβ3, αvβ5 and αvβ6), cytokeratin and
vimentin in uninfected bovine pharynx cell cultures was analyzed by IHC using speciﬁc antibodies to the indicated proteins to determine the level of expression at passage
4 and passage 15. (B) Micrographs of mock and persistently infected bovine pharynx cultures at passage 1 and passage 15, the level of viral infection is evidenced by CPE.
(C) Detection of the presence of FMDV RNA by real-time RT-PCR is indicated by Ct value, FMDV infectivity (expressed as pfu/mL) and FMDV antigen, as detected by IHC using
a speciﬁc MAb, 10GA, that recognizes structural protein VP1 in passages 2 and 15 in persistent bovine pharynx cell cultures.
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demonstrated an expanded capacity to grow in most of the cell
lines tested, compared with persistent O1Man-Ph15 (Fig. 4B).
O1Manisa-par virus yields were comparable among all cell lines
tested with the exception of EBK, which produced 100 to 1000
times less infectious particles than any of the others. O1Man-Ph15
virus yields were similar in all of the tested cell lines.
In order to test co-adaptation of the persistent virus and PBPT
cultures, we compared the growth kinetics of the persistent virus
O1Man-Ph15 to that of the parental virus O1Manisa-par in PBPT
cultures at two different passage levels (passage 4 versus passage 19).
Cell monolayers were infected with each virus at low MOIs (0.01 pfu/
cell) and at the indicated times post-infection samples were taken and
titrated on LFBK cells. While O1Man-Ph15 virus grew similarly in the
two passages of PBPT cultures, O1Manisa-par virus showed a marked
growth decrease (approximately 3 logs) in PBPT passage 19 compared
to its replication in PBPT passage 4 and compared to O1Man-Ph15
growth (Fig. 4C). Furthermore, another wild-type FMDV, O1 Campos,
assessed in similar conditions had similar growth characteristics as
O1Manisa-par virus in terms of its replication in culture passages
4 and 19 (Fig. 4D). These results indicate that virus released from the
persistent cultures contained phenotypic alterations in terms of plaque
morphology, the pattern of growth ability in different susceptible cells
lines and increased replication in cultured pharynx cells compared to
the parental virus. This is evidence that the persistent virus has
adapted to the pharynx cells and that the cells have also been
modiﬁed during serial passages.
Similarly, earlier studies using a persistently FMDV-infected
BHK-21 cell culture have shown the existence of a co-evolution
O1Man-Ph15 Mock
Clathrin Caveolin-1 Golgi PDI
Rab 11 Proteosome Vimentin
IVTubulin Tubulin Tubulin Actin
Rab 4
γβ α
Fig. 2. Analysis of the distribution of FMDV viral antigens and cell markers by IFA in persistently infected cultures. (A) Detection of FMDV VP1 protein in bovine pharynx
persistently infected cultures (passage 15) and in mock culture as a control. Cells were ﬁxed and probed, as described in “Material and Methods”. FMDV structural protein VP1
was detected with a speciﬁc MAb, 10GA, and visualized with Alexa Fluor 594 (red). (B) Distribution of FMDV viral protein VP1 and different cellular markers. Cells were ﬁxed and
processed by immunoﬂuorescence as described in “Materials and Methods”. FMDV structural protein VP1 was detected by using MAb 10GA, and visualized with Alexa Flour 594
(red) and the indicated cellular markers (clathrin, caveolin-1, golgi, PDI, Rab4, RAb11, proteosome, vimentin, tubulins, and actin) visualized with Alexa Fluor 488 (green).
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between the cells and the virus which occurs along the serial
passages (de la Torre et al., 1988; Escarmis et al., 1998; Martin
Hernandez et al., 1994). In our system, using PBPT cells, there is a
mixed cell population, which may allow a wide selection of
different cell types that would have a natural increased ability to
resist cytopathic infection with the parental virus. As previously
described in the BHK-21 model (de la Torre and Domingo, 1988),
the persistent virus isolated in the PBPT system was able to grow
equally well in the parental cell culture and cells obtained after
subsequent passages.
Receptor usage by FMDV recovered from persistently infected bovine
pharynx cultures
It has been well established that FMDV utilizes at least four
members of the αv subgroup of cellular integrins (αvβ1, αvβ3,
αvβ6 and αvβ8) as receptors in vitro (Berinstein et al., 1995; Duque
and Baxt, 2003; Jackson et al., 2004; Jackson et al., 2002; Neff
et al., 1998; O’Donnell et al., 2005). In the process of characteriza-
tion of the persistent virus, it was important to analyze if the
changes in the ability of the virus to replicate in different cell types
involve changes in the utilization of these integrins as receptors.
COS cells were transfected with all four different bovine integrins:
αvβ3, αvβ6, αvβ1 and αvβ5, then infected with either O1Manisa-
par or the persistent virus O1Man-Ph15. Expression of integrins in
the transfected COS cells was evaluated by IHC (Fig. 5B). Results
showed that the parental virus, as expected, utilizes αvβ6 as a
receptor since the virus was passaged in BHK-αvβ6 cells.
Conversely, after 15 passages, O1Man-Ph15 virus appears to not
use any of the four integrin receptors (Fig. 5A).
As previously described, some tissue culture-adapted FMDVs
gain the ability to utilize cell surface heparin sulfate (HS) as a viral
receptor (Baranowski et al., 1998; Henley et al., 1998; Martinez
et al., 1997; Neff et al., 1998; O’Donnell et al., 2008), with in vivo
attenuation associated with this change (Sa-Carvalho et al., 1997).
To determine if HS plays a role as a receptor for the establishment
of O1Man-Ph15 as persistent virus, CHO-K1 cells expressing HS
receptor and CHO-677 cells, which do not express HS receptor,
were infected with FMDV strain vCRM4-KGE (as a control for HS
receptor use), O1Manisa-par or O1Man-Ph15 at a low MOI
(0.01 pfu/mL), and virus yields were determined by plaque assay
on LFBK cell monolayers. Results demonstrated that neither of the
assessed FMDVs grew in CHO-677 cells while only vCRM4-KGE
was able to grow in CHO-K1 cells (Fig. 5C). These results indicate
that the O1Manisa-par as well as O1Man-Ph15 does not use HS as
a receptor. Although we do not have any experimental evidence,
these results suggest the possibility that O1Man-Ph15 utilizes a
currently unidentiﬁed cellular receptor (Zhao et al., 2003).
Genotypic characteristics of FMDV recovered from persistently
infected bovine pharynx cultures
In an attempt to deﬁne the molecular basis of the phenotypic
modiﬁcations observed in the persistent virus O1Man-Ph15, its
entire genomic sequence was determined and compared to the
parental virus genome (Table 1). Interestingly, only three amino
Fig. 3. Detection of autophagy markers by using speciﬁc antibodies to the indicated proteins (LC3, Atg5 and Atg12) in FMDV persistently (15 passages) and acute infected
cultures using IFA. As a control mock passed cells at passage 5 and passage 19 were used. Autophagy markers LC3, Atg5 and Atg12 were visualized with Alexa Fluor 488
(green) and FMDV structural protein VP1 with Alexa Fluor 594 (red).
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acid residues were substituted in the O1Man-Ph15 genome: two in
the structural protein VP1 – T43A and E83K; and one in the non-
structural protein 2A – L211P.
To determine the possibility that any of the mutations observed
in O1Man-Ph15 may potentially disrupt functional linear motifs, the
VP1 of O1Man-Ph15 virus was analyzed using the Eukaryotic Linear
Motif resource server (ELM server available at http://elm.eu.org).
The mutation of residue T43A in VP1 caused the disruption of
several potential linear motifs (Table 2) since threonine is an
essential residue within these motifs. In this area there is a
predicted MAPK phosphorylation site, suggesting phosphorylation
of Thr43 would be disrupted by the T43A mutation observed in
O1Man-Ph15. Perhaps VP1 could be phosphorylated during infec-
tion, and phosphorylation of Thr43 would result in the potential for
this area to be both a ligand for WW domain- and FHA domain-
containing proteins. Proteins harboring either WW or FHA domains
have been shown to recognize phosphothreonine epitopes to
mediate protein–protein interactions (Durocher et al., 1999). These
domains are associated with proteins involved in a wide range of
cellular processes including intracellular signal transduction, tran-
scription, protein transport, DNA repair and protein degradation
(Durocher et al., 2000; Li et al., 2000).
In regards to the mutations at positions 83 of VP1 (Glu to Lys)
and 211 of 2A (Leu to Pro), these positions are not part of any
previously described critical region of VP1 (Carrillo et al., 2005) or
of the essential cleavage domain of 2A (Donnelly et al., 2001), nor
of other identiﬁable functional motifs.
Other studies support the low incidence of amino acid sub-
stitution as observed in O1Man-Ph15 in the PBPT system. The P1
region of FMDV obtained after 100 passages of persistently
infected BHK-21 cell cultures displayed only 9 amino acid changes
ﬁxed in the structural proteins (Diez et al., 1990a). Importantly,
persistent virus became more attenuated with successive culture
passages when inoculated into mice and cattle (Diez et al., 1990b).
Interestingly, the sequence of the VP1-coding region of the virus
isolated from persistently infected cattle or water buffalo indicated
a low nucleotide variability compared with the parental virus,
leading to only 2–6 amino acid changes per genome, with most
mutations in areas comprised of residues 40–50 and 135–151
(Barros et al., 2007; Gebauer et al., 1988). It appears that passage of
persistently infectious virus either in vitro or in vivo has a low rate
of accumulation of amino acid residue substitutions, and that
these substitutions tend to occur in the structural proteins
of FMDV.
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Fig. 4. Phenotypic characterization of FMDV recovered from persistent bovine pharynx cultures. (A) Plaque morphology as determined by pfu/mL in LFBK cells. (B) Ability of
the persistent virus, O1Man-Ph15, to replicate in a number of different cell types (BHK-21, BHK-21 αvβ6, LFBK, EBK, FBK, pharynx, FPK, SK-6 and IBRS-2 cells), compared to
the parental virus, O1Manisa-par. (C) Growth kinetics of the persistent virus O1Man-Ph15 to that of the parental virus O1Manisa-par in bovine pharynx cell cultures at two
different passage levels (passage 4 versus passage 19). Cells were infected with each virus at low MOIs (0.01 pfu/cell) and at the indicated times post-infection samples were
taken and titrated on LFBK cells as described in “Materials and Methods”. Results are expressed as Log 10 TCID50/ml. (D) Comparison of virus yield of O1Manisa-par and
O1Man-Ph15 along with wild-type FMDV O1 Campos in bovine pharynx cell cultures at two different passage levels (passage 4 versus passage 19). Results are expressed as
Log 10 TCID50/ml. Panels (C) and (D) show results from one of two independent sets of experiments.
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O1Man-Ph15 persistently infected bovine pharyngeal cell cultures are
resistant to FMDV superinfection
To understand the establishment of the persistent infection in PBPT
cell cultures, we investigated if persistently infected cells are
susceptible to superinfection with another FMDV or by non-related
viruses. Persistent O1Man-Ph15-infected bovine pharynx cell cultures
were subsequently infected with FMDV type A24 at an MOI of 1.
Speciﬁc monoclonal antibodies to VP1 against each serotype, A24 or
O1 Manisa (Stave et al., 1986), were used to differentiate the cells
infected with either virus. Results demonstrated that some cells
showed a clear expression of FMDV A24 or O1 Manisa VP1, but no
cells could be detected expressing simultaneous VP1 from both FMDV
serotypes (Fig. 6A). Thus, none of the cells persistently infected with
FMDV O1 Manisa were superinfected with FMDV-A24. To conﬁrm this
result, the efﬁciency of FMDV A24, as well as non-related viruses, VSV
and BEV, to replicate on the persistently infected bovine pharynx
culture was analyzed by plaque assay. Infection of persistent O1Man-
Ph15 culture with FMDV A24 resulted in viral yields 105 times lower
than those obtained when naive bovine pharynx cultures were
infected (Fig. 6B). VSV and BEV replicated in uninfected bovine
pharynx cells with a similar efﬁciency as in the persistent O1Man-
Ph15 culture (Fig. 6B).
In accordance with this data, it has been previously reported
that persistently FMDV-infected BHK-21 cells producing nearly
undetectable amounts of virus at passage 100 resisted infection
with homologous and heterologous FMDV, but were permissive to
VSV, SFV and EMCV (de la Torre et al., 1985). Therefore, persistent
infection of the PBPT cultures makes them speciﬁcally resistant to
FMDV superinfection, yet they remain susceptible to other viruses.
Consequently, the mechanism mediating the resistance should be
related to a metabolic step that is unique to FMDV replication.
Cytokine expression in persistently FMDV-infected bovine pharynx
cultures
In an attempt to understand the events governing the estab-
lishment of the persistent infection in the PBPT cultures, the
pattern of gene expression of selected cytokines was assessed.
The patterns of O1Man-Ph15 persistently infected cultures were
compared with those of PBPT cultures acutely infected with
O1Manisa-par. The virus input used in the infection was adjusted
to a MOI resulting in a percentage of infected cells similar to that
of the persistently infected cultures. Results obtained showed that
the persistently infected cultures presented approximately 10-fold
down-regulation of IL-1β, IFN-α, IL-12, IL-2, IL-15, INOS and more
than 100-fold down-regulation of IP-10 compared with the lytic
infection (Fig. 7). No relative increase in the transcription of any of
the cytokines evaluated was detected. This suggests that the
absence of key antiviral cytokines may allow persistent infection
of the cells. To assess this possibility, passage 15 of the PBPT
cultures was treated with IFN-α or IFN-γ for 3 days at a concen-
tration of 10 ng/mL and 50 U/mL, respectively. Samples were taken
daily and the presence of infectious virus determined by plaque
assay in LFBK cells. Interestingly, while IFN-α did not alter the
virus yields, treatment with IFN-γ efﬁciently and permanently
suppressed virus replication (Fig. 8).
Our results are in accordance with those previously reported
showing that pretreatment of persistently infected primary bovine
VP0
VP1
VP3
VP2
VP4
O1Man-par O1Man-Ph15
N
on
 tx
a V
b 3
a V
b 1
a V
b 5
a V
b 6
L
FB
K
N
on
 tx
a V
b 3
a V
b 1
a V
b 5
a V
b 6
L
FB
K
CHO-K1 cells
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
O1Man par O1Man-Ph15 vCRM4-KGE
L
og
10
-D
iff
er
en
ce
 in
 ti
te
r 
(2
4h
/0
h)
αVβ1 αVβ3 αVβ5 αVβ6Control 
Fig. 5. Receptor usage by FMDV recovered from persistently infected bovine
pharynx cultures. (A) Role of integrins as a receptor. COS-1 cells were transfected
with all 4 integrins: αvβ3, αvβ6, αvβ1 and αvβ5, and infected with the parental virus
O1Manisa-par or the persistent virus, O1Man-Ph15, as described in “Materials and
Methods”. (B) Expression of integrins in transfected COS-1 cells by IHC. Integrin
expression in COS-1 cells transfected with all 4 integrins was analyzed by IHC, by
using MAbs to the integrins αVβ3, β1, β5 or β6. (C) Role of heparin sulfate (HS) as a
receptor. CHO-K1 cells that express HS receptor and CHO-677 are lacking the HS
receptor were infected with vCRM4-KGE, O1Manisa-par, or O1Man-Ph15, and
samples were taken at 24 h. Results are expressed as pfu/mL: difference of virus
yield at 24 hpi–0 hpi.
Table 1
Amino acid replacements in viruses derived from persistently infected bovine
pharynx cultures, compared to the parental virus, O1Man-par.
Protein Position O1Man-
par
O1Man-
Ph15
Codon # in
gene
AA in
parental
Substitution
VP1 3397 A G 43 Thr Ala
VP1 3517 G A 83 Glu Lys
2A 3908 T C 2 Leu Pro/Leu
Table 2
Motifs disrupted in the O1Man-Ph15 virus.
Motif name Motif Probability Position
FHA phosphopeptide ligand ..(T)..[DE]. 0.0083 41–47
WW domain ligand …[ST]P. 0.0154 40–45
MAPK phosphorylation site ..[ST]P.. 0.0154 40–46
Amino acids in [] could be either amino acid. A (.) represents any amino acid can be
in this position of the motif.
V. O’Donnell et al. / Virology 468-470 (2014) 185–196 191
thyroid cells with recombinant IFN-γ profoundly affected FMDV
growth (Zhang et al., 2002). This study suggested the possibility
that a cytokine-mediated pathway may be involved in the in vivo
clearance of persistent FMDV.
In summary, we report here the establishment of FMDV persis-
tence in primary cells derived from bovine pharynx, a primary site for
virus replication (Alexandersen et al., 2003; Ruiz-Saenz et al., 2009).
This report constitutes the establishment of a persistent culture
derived from a relevant bovine tissue. We conclude that persistent
infection of bovine pharynx cells with FMDV could be established and
that multiple genetic and phenotypic variations occur within the virus
and cells during persistence, suggesting co-evolution of the virus and
cells. The establishment of a relevant bovine tissue persistently FMDV-
infected in vitro system may provide a successful model to aid in the
understanding of the molecular mechanisms of induction, reactivation
and potentially clearance of FMDV in carrier animals.
FMDV-A24 BEV VSV
Mock Pharynx 9 x 107 PFU/ml 3.5 x 107 PFU/ml 4 x 107 PFU/ml
O1Man-Ph- 15 3.5 x 102 PFU/ml 7.5 x 107 PFU/ml 4 x 107 PFU/ml
6B
6A
6A
6B
Fig. 6. Persistently FMDV-infected bovine pharynx cultures are resistant to superinfection by homologous virus but not heterologous virus. (A) Monolayers of persistent
O1Man-Ph15 were infected with FMDV type A24 (MOI¼1). Speciﬁc monoclonal antibodies to VP1 against serotype A24 or O1Manisa were used to detect VP1 in the
superinfected cultures by IFA as described in “Materials and Methods”. Panels 6A and 6B are enlargements of selected areas in the panel on the left. (B) Efﬁciency of
homologous (FMDV A24) and non-related heterologous viruses (VSV and BEV) to replicate in the persistently infected bovine pharynx culture as determined by plaque assay.
Titers were expressed as pfu/mL.
Fig. 7. Cytokine proﬁle in bovine pharynx cultures persistently infected passage 15 PBPT or acutely infected for 5 h with FMDV was detected by real-time PCR, using primers
for the indicated cytokines. O1Man-Ph15 persistently infected cultures were compared with those of PBPT cultures acutely infected with O1Manisa-par. Results are
expressed in fold increase/decrease of RNA compared with cells that were mock-infected cells.
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Material and methods
Cell lines and virus
FMDV type O1 strain Manisa was derived from the vesicular
ﬂuid of an infected steer that was then passaged twice in bovine.
Parental viral stocks (O1Manisa-par) were grown in a derivative of
BHK-21 (ATCC, Catalog number CCL-10) cells expressing the
bovine αVβ6 integrin (BHK-αVβ6) (Duque et al., 2004). The viral
titer was determined by plaque assay on a bovine kidney cell line
(LFBK) using standard techniques (Pacheco et al., 2010).
Bovine epithelial cultures from soft palate and pharynx
Monolayer cultures of primary bovine epithelial cells from the
pharynx and dorsal soft palate (PBPT) were prepared by using a
modiﬁcation of a method for preparing bovine lingual epithelial
keratinocyte cultures (Barlow and Pye, 1990; O’Donnell et al.,
2001). Brieﬂy, freshly harvested bovine pharynx and dorsal soft
palate were washed with PBS media containing 500 U/mL peni-
cillin, 500 mg/mL streptomycin, 1.25 mg/mL fungizone and 0.25 mg/
mL gentamicin. The layers of the epithelial tissue were dissected
from the muscle. Then, the epidermis was cut into small pieces
and placed in a sterile plastic Petri dish with Dispase solution
containing 25 mM HEPES and antibiotics (Dispaseþ) and incu-
bated at 4 1C overnight to release the epidermis from the under-
lying basement membrane. After 24 h, the Dispaseþ was replaced
with fresh Dispaseþ and the tissue was incubated for 1 h at 37 1C
or longer if needed. After the incubation with Dispaseþ , the
epidermis was peeled off using sterile tweezers and a scalpel
blade. The pieces of epithelia were transferred into a 50 mL conical
tube containing 0.25% trypsin and incubated at room temperature
(RT) for 1 h with rotation. The cell suspension was pipetted into a
50 mL tube and 10% heat inactivated FBS (HIFBS) was added before
placing the cells on ice. Fresh trypsin (0.25%) was added to the
pieces of tissue and the trypsinization repeated up to 5 times. The
cells from all the trypsinizations were combined, ﬁltered through a
0.75 mm cell strainer, centrifuged for 10 min at 2500 rpm, resus-
pended in media and counted. These preparations were plated
directly onto T-150 ﬂasks at a density of 3–4107 cells per ﬂask in
pharynx growth media (MEM, 20% HIFBS, 1% antibiotics/antimy-
cotic, 0.25 mg/mL gentamicin, 6.46 mg/mL polymyxin B, and 1%
glutamine). Once a monolayer was obtained, cells were frozen
down at 0.5–1107 cells/vial. Frozen cells were gently thawed
and plated directly as described below. The cells obtained to
develop the persistent culture were negative for FMD virus before
the in vitro infection, as determined by immunohistochemistry
(IHC), real-time reverse transcription-PCR (RT-PCR) and virus
isolation (3 blind passages in LFBK cells).
Viral growth curve
Growth curves were performed in primary bovine pharynx
cells or LFBK cells. Cell monolayers were prepared in 24-well
plates and infected with the parental virus, O1Manisa-par, or with
O1 Manisa virus obtained from persistently infected cell cultures
passaged 15 times (O1Man-Ph15) at an MOI of 0.001 pfu/cell for
1 h at 37 1C. At the end of the adsorption period, the inoculum was
removed and the cells were rinsed with ice-cold 2-morpholi-
noethanesulfonic acid (MES)-buffered saline (25 mM MES, pH 5.5,
and 145 mM NaCl) to remove residual virus particles. The mono-
layers were then rinsed with MEM (Invitrogen) containing 1% fetal
bovine serum and 25 mM HEPES (pH 7.4) and incubated for 0, 4, 8,
24 and 48 h at 37 1C. At the appropriate times post-infection (p.i.),
the cells were frozen at 70 1C and the thawed lysates were used
to determine titers by plaque assay using LFBK cells.
Comparative ability of viruses to replicate in different cells
The following cell types were selected for this study: primary
embryonic bovine kidney cells (EBK, kindly provided by
Dr. S. Wessman, USDA, APHIS, Ames, Iowa), primary bovine
pharynx (PBPT, described above) and primary fetal bovine and
porcine kidney (FBK and FPK, respectively), as well as the follow-
ing cell lines: BHK-21, BHK-αVβ6, LFBK, SK6 and IBRS-2. The ability
of O1Manisa-par and O1Man-Ph15 to replicate in these cell types
was determined by preparing serial 10-fold dilutions of virus to
assess cytopathic effect (CPE) using each cell type; the resulting
data was used to calculate the 50% tissue culture infectious dose(s)
(TCID50). Titers were calculated using the method of Reed and
Muench (1938) and expressed as TCID50/mL. All samples were run
simultaneously to avoid inter-assay variability.
Antibodies and reagents
Monoclonal antibody 10GA directed against FMDV type O1
structural protein VP1 was used as previously described (Stave et
al., 1986). MAbs LM609 (Catalog no. MAB1976), which recognizes
the αVβ3 heterodimer, and CSβ6 (Catalog no. MAB2076), which
recognizes the αVβ6 heterodimer, were purchased from Chemicon
International (Billerica, MA). Further characterization of the per-
sistently infected cells was performed using MAbs against cyto-
keratin (marker for epithelial cells (clone K8.13, Sigma)); vimentin
(Clone V9, Sigma); actin (MAB1501, Chemicon International) and
α-tubulin (cytoskeleton markers); clathrin heavy chain and
caveolin-1 (MA1-065 and PA1-064, respectively; Afﬁnity Biorea-
gents) (markers for clathrin and caveolae endocytosis pathways,
respectively) MAb against the endoplasmic reticulum marker
protein disulﬁde isomerase (PDI); Golgi zone area MAb to detect
the Golgi apparatus (MAB 1271, Chemicon International); Rab11 to
identify recycling endosomes (Afﬁnity Bioreagents) and proteo-
somes, as a marker to determine if virus is degraded in these
structures. To identify the cellular structures the persistent virus is
associated with, a rabbit polyclonal antibody against LC3 (Ana-
Spect, San Jose, CA) was used to identify autophagosomes; rabbit
polyclonal antibodies against APG5 and APG12 (Santa Cruz, Dallas
TX) were used.
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Fig. 8. Effect of IFN treatment on virus yield in persistently infected bovine
pharynx cultures. O1Man-Ph15 persistently infected cultures were treated with
either IFN-γ or IFN-α for 3 days at a concentration of 10 ng/mL or 50 U/mL,
respectively. Samples were taken daily and the presence of infectious virus
determined by plaque assay in LFBK cells. Cessation of IFN-γ or IFN-α treatment
at 72 h was followed by trypsinization of the cultures and an additional 4 days of
culture without treatment. Samples were taken at day 7 post-treatment and the
presence of infectious virus was determined as before. Results represent one of two
independent sets of experiments.
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Immunoﬂuorescence and confocal microscopy
Monolayers of bovine pharynx cells persistently infected with
FMDV or mock infected were grown on 12-mm glass coverslips in
24-well tissue culture dishes, then ﬁxed with 4% paraformalde-
hyde (EMS, Hatﬁeld, PA) and processed for immunoﬂuorescence
and confocal microscopy as previously described (O’Donnell et al.,
2005). Brieﬂy, after ﬁxation the paraformaldehyde was removed
and cells permeabilized with 0.5% Triton X-100 for 5 min at room
temperature (RT) then incubated in blocking buffer (phosphate
buffered saline [PBS], 5% normal goat serum, 2% bovine serum
albumin, and 10 mM glycine) for 1 h at RT. The cells were
incubated with the primary antibodies overnight at 4 1C. When
double-labeling was performed, cells were incubated with both
antibodies together. After a PBS wash, cells were incubated with
the appropriate secondary antibodies labeled with Alexa Fluor
(Life Technologies, Grand Island, NY) for 1 h at RT. Following this
incubation, cells were washed 3 times with PBS, counterstained
with the nuclear stain TOPRO-iodide 642/661 (Life Technologies)
for 5 min at RT, washed, mounted, and examined using a Leica
scanning confocal microscope (model TCS2). Data was collected
utilizing appropriate prepared controls lacking the primary anti-
bodies, as well as the anti-FMDV antibodies with uninfected cells
to give the negative background levels and to determine channel
crossover settings. The captured images were adjusted for contrast
and brightness using Adobe Photoshop software.
Immunohistochemistry
Monolayers of bovine pharynx cells persistently infected or
mock infected grown on 12-mm glass coverslips in 24-well tissue
culture dishes were ﬁxed with Acetone:Methanol (1:1) and
processed for immunohistochemistry as previously described
(O’Donnell et al., 2009). Brieﬂy, after ﬁxation cells were rehydrated
with blocking buffer (phosphate buffered saline [PBS, 0.01 M, and
pH 7.4], 2% bovine serum albumin, and 20% normal bovine serum)
for 30 min at RT. The cells were then incubated with the primary
antibodies for 30 min at RT. After cells were washed with PBS, the
primary antibody was detected with biotinylated anti-mouse IgG
and ABC-peroxidase substrate (Vector Laboratories, Burlingame,
CA). The cells were then mounted (Vector Laboratories) and
examined by microscopy.
Transient expression of integrin subunits in COS-1 cells and viral
replication assays
COS-1 cells were transfected with plasmids expressing the
integrin subunits αV and β1, β3, β5 or β6 by using the Fugene
(Promega, Madison, WI) reagent following the procotol as indi-
cated by the manufacturer. At 24 h post-transfection, cells were
infected with the original virus (O1Manisa-par) or with virus
recovered from persistent cultures at the indicated passage num-
ber. After the 1-h adsorption period, the cells were labeled over-
night with 100 uCi of [35S]-methionine in methionine-free
medium. At the end of the labeling period, monolayers were
washed twice with PBS, resuspended in 1X RIPA lysis buffer
(10 mM Tris–HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton
X-100, 0.1% SDS, and 1% sodium deoxycholate), incubated for
10 min on ice, clariﬁed by centrifugation at 14,000 rpm for
10 min at RT, and stored at 70 1C. Viral replication was deter-
mined by radioimmunoprecipitation (RIP) of equal amounts of
trichloroacetic acid-precipitable count per minute of lysate by
using MAb directed to FMDV type O1, as described previously (Neff
et al., 2000). Immunoprecipitated proteins were resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) using a 12.5% polyacrylamide gel, and the gels were dried
and exposed to X-ray ﬁlm to produce autoradiograms revealing
the sizes of the different viral proteins. Transfected cells in one of
the wells were not infected but were analyzed for integrin
expression by immunohistochemistry as described previously
(Neff et al., 2000) by using MAbs directed to the human integrins
αVβ3, β1, β5 or β6 (all antibodies from Millipore, Billerica, MA).
Reverse transcription and quantitative real-time polymerase chain
reaction
Cells were grown for the indicated time in a T-75 ﬂask, washed
twice with 1X PBS, then twice with 0.05% Trypsin EDTA and left at
room temperature until cells were detached. The detached cells
were resuspended in 10 mL of growth media and centrifuged for
10 min at 1000 rpm. Media was poured off and the pellet was
resuspended in 700 mL RLT lysis buffer (Qiagen, Valencia, CA). The
lysate was transferred to a Qiagen Qiashredder (Qiagen), and total
RNA was subsequently isolated using an RNeasy kit (Qiagen) as
recommended by the manufacturer. RNA concentrations were
determined using a NanoDrop ND-1000 spectrophotometer. 1 mg
of RNA was treated with DNase I per manufacturer's instructions
(Sigma, St. Louis, MO) and total RNA was reverse transcribed into
cDNA using random hexamers (Thermo Scientiﬁc Hanover Park, IL)
per manufacturer's recommendations. Brieﬂy, the 25 mL reactions
contained 11 mL of DNase-treated RNA, 5 mL of 5X First-Strand
Buffer (250 mM Tris–HCl, 375 mM KCl, and 15 mM MgCl2), 2.5 mL
of 0.1 M DTT, 2.5 mL of random hexamers (125 ng/mL), 1.25 mL of
RNaseOUT Recombinant Ribonuclease Inhibitor (Invitrogen
#10777-019), 1 mL (200units) of Moloney Murine Leukemia Virus
Reverse Transcriptase (Invitrogen #28025-013), 0.125 mM deox-
ynucleoside triphosphates (Applied Biosystems #N808-0007, Fos-
ter City, CA) and 0.5 mL water. First-strand cDNA synthesis thermal
parameters were as follows: 25 1C for 10 min, followed by 37 1C for
60 min, then 95 1C for 5 min. The cDNA was then diluted 1:8 with
nuclease-free water in a ﬁnal volume of 200 mL. Cytokine real-time
PCR was performed using an ABI 7000 Sequence Detection System.
Brieﬂy, the 25 mL reactions contained 12.5 mL TaqMan 2X PCR
Master Mix (Applied Biosystems #4304437), primers (300 nM
each, Invitrogen), TaqMan 6FAM-labeled ﬂuorogenic probe
(150 nM, Applied Biosystems), 4.5 mL water, and 2 mL of cDNA
template. Real-time PCR cycling parameters were as follows: 50 1C
for 2 min, 95 1C for 10 min, then 40 cycles of 95 1C for 15 s and
60 1C for 60 s. Primers are described in Table 3.
Baseline levels of GAPDH expression (a house-keeping gene)
and 19 host genes of interest (IL-1B, IFN-α, INF-β, IL-6, IL-12, IL-2,
TNF-α, IL-4, IL-10, IL-15, IL-18, IFN-γ, TGF, INOS, IP-10, RANTES,
OAS, PKR, and MX-1) were established using Dorsal Soft Palate
cDNA from mock-inoculated steers (n¼3) by real-time PCR. cDNA
was run in triplicate and averaged for each individual specimen.
The triplicate averages of the 3 steers were then averaged to
generate the negative control baseline cycle threshold (Ct) for all
19 genes of interest. cDNA real-time PCR was carried out in 25 mL
reactions on the ABI 7000 Sequence Detection System as
described above.
DNA sequencing and analysis
Full-length clones and in vitro-rescued viruses were completely
sequenced with FMDV-speciﬁc primers by the dideoxynucleotide
chain-termination method (Sanger et al., 1977). Viruses recovered
from infected cultures were sequenced in the mutated region.
Sequencing reactions were prepared with the Dye Terminator
Cycle Sequencing Kit (Applied Biosystems). Reaction products
were sequenced on an ABI PRISM 3730xl automated DNA
sequencer (Applied Biosystems). Sequence data were assembled
with the Phrap software program (http://www.phrap.org), with
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conﬁrmatory assemblies performed using CAP3 (Huang and
Madan, 1999). The ﬁnal DNA consensus sequence represented an
average ﬁve-fold redundancy at each base position. Sequence
comparisons were conducted using BioEdit software (http://
www.mbio.ncsu.edu/BioEdit/bioedit.html).
IFN-alpha and -gamma treatment of infected pharynx cultures
Bovine pharynx cells persistently infected with FMDV O1
Manisa were added to 6-well plates and monolayers were allowed
to form (24 h). The cultures were then treated with IFN-gamma
(10 ng/mL), IFN-alpha (50 U/mL), or mock-treated. Cell culture
supernatants were harvested after 24, 48 or 72 h of treatment
for virus isolation by plaque assay. The recovery of virus after
removal of IFN was further examined. Cessation of IFN-gamma
treatment at 72 h was followed by trypsinization of the cultures
and an additional 4 days of culture without treatment. Cessation of
IFN-alpha treatment at 72 h was followed by trypsinization of the
cultures and an additional 4 days of culture without treatment.
Cell culture supernatants were harvested and virus quantitation
was determined by plaque assay and real-time RT-PCR.
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Table 3
Primer and probe sequences of mRNA real-time PCR detection systems.
Gene Forward primer 5ʹ–3ʹ Probe 5ʹ–3ʹ Reverse primer 5ʹ–3ʹ GenBank accesssion #
IL-1B AAAGCTTCAGGCAGGTGGTG CCGGTCATCGTGGCCATGGAGAAG TGCGTAGGCACTGTTCCTCA M35589
IFN-α AGCACACCTTCCAGCTTTTCA CAGAGGGCTCGGCC GGAGGCTCTTGTCCCACACA M10953
IFN-β CTACAGCTTGCTTCGATTCCAA ACGTCAGAGCCTTAAA CTGCCCCAGGAGTTTCTGAC M15477
IL-6 CAGCTATGAACTCCCGCTTCA AAGCGCCTTCACTCCATTCGCTGTC AGGAGCAGCCCCAGGG NM173923
IL-12 CCAAAGTCACATGCCACAAGG TGCCAACGTCCGCGTGCAA CTGTAGTAGCGGTCCCGGG NM174356
IL-2 GGATTTACAGTTGCTTTTGGAGAAA TTAAAAATCCTGAGAACCTC CAAATGTATGCATCCTGGAGAGC M13204
TNF-α CGGTGGTGGGACTCGTATG CAATGCCCTCATGGCCAACGG GCTGGTTGTCTTCAAGCTTCA Z48808
IL-4 TTGAACAAATTCCTGGGCG CCTGACAGGAATCTC GGTCTTGCTTGCCAAGCTGT M77120
IL-10 GGTGATGCCACAGGCTGAG CACGGGCCTGACATCAAGGAGCA AGCTTCTCCCCCAGTGAGTTC U00799
IL-15 GGCTGGCATTCATGTCTTCA TTTGGGCTGTATCAGTGCAAGTCTTCCC CATACTGCCAGTTTGCTTCTGTTT NM174090
IL-18 GTCTACTCTCTCCTGTGAGAACAA TCCTTTAAGGAAATGAATCCTCCTGATAACA AATATGATGTCACTTTCTTCATTATCA NM174091
IFN-γ GGAGGACTTCAAAAAGCTGATTCA TTCCGGTGGATGATC GCTTTGCGCTGGATCTGC M29867
TGF-1B AACAATTCCTGGCGCTACCTC CTCACCGGAGTGGCTGTCCTTTGAC TGCCGCACAACTCCAGTG NM001166068
iNOS GGCCCAGGAAATGTTCGAA AGACACGTGCGTTATGCCACCAACAA ACAGTGATGGCCGACCTGAT DQ676956
IP-10 AAGTCATTCCTGCAAGTCAATCCT CCACGTGTCGAGATTATTGCCACAATGA TTGATGGTCTTAGATTCTGGATTCAG NM001046551.1
RANTES CCCTGCTGCTTTGCCTATATCT CCCGCACCCACGTCCAGGAGT GCACTTGCTGCTGGTGTAGAAA EU276060.1
OAS CCAAAGTTGTGAAGGGTGGC CTCAGGCAAAGGC TGATCGTCCCCTGAGGGTC NM178108
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